CANTEX PHARMACEUTICALS INC. 13D/13G Filings for Chimerix, Inc. (CMRX)

CANTEX PHARMACEUTICALS INC. 13D and 13G filings for Chimerix, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-03
4:16 pm
Sale
2021-12-31 13G Chimerix, Inc.
CMRX
CANTEX PHARMACEUTICALS INC. 3,500,000
4.000%
-6,500,000decrease
(-65.00%)
Filing